| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.61e-04 | 5 | 81 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 1.75e-04 | 27 | 81 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | acrosin binding | 2.41e-04 | 6 | 81 | 2 | GO:0032190 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 4.48e-04 | 8 | 81 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 5.74e-04 | 9 | 81 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 5.78e-04 | 709 | 81 | 10 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein kinase activity | 7.16e-04 | 600 | 81 | 9 | GO:0004672 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 8.73e-04 | 11 | 81 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | kinase activity | 1.02e-03 | 764 | 81 | 10 | GO:0016301 | |
| Domain | TAF_II_230-bd | 1.81e-05 | 2 | 80 | 2 | IPR009067 | |
| Domain | TFIID_sub1_DUF3591 | 1.81e-05 | 2 | 80 | 2 | IPR022591 | |
| Domain | - | 1.81e-05 | 2 | 80 | 2 | 1.10.1100.10 | |
| Domain | TBP-binding | 1.81e-05 | 2 | 80 | 2 | PF09247 | |
| Domain | DUF3591 | 1.81e-05 | 2 | 80 | 2 | PF12157 | |
| Domain | TAF1_animal | 1.81e-05 | 2 | 80 | 2 | IPR011177 | |
| Domain | ZnF_U1 | 2.55e-04 | 29 | 80 | 3 | SM00451 | |
| Domain | Znf_U1 | 2.55e-04 | 29 | 80 | 3 | IPR003604 | |
| Domain | Znf_C2H2_matrin | 1.16e-03 | 12 | 80 | 2 | IPR000690 | |
| Domain | TUDOR | 1.59e-03 | 14 | 80 | 2 | PF00567 | |
| Domain | AMP-bd_C | 2.36e-03 | 17 | 80 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 2.36e-03 | 17 | 80 | 2 | PF13193 | |
| Domain | ZF_MATRIN | 2.65e-03 | 18 | 80 | 2 | PS50171 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.65e-03 | 18 | 80 | 2 | IPR008930 | |
| Domain | - | 3.05e-03 | 333 | 80 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.14e-03 | 335 | 80 | 6 | IPR015943 | |
| Domain | Semaphorin | 3.27e-03 | 20 | 80 | 2 | IPR027231 | |
| Domain | Znf_C2H2_jaz | 3.96e-03 | 22 | 80 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 3.96e-03 | 22 | 80 | 2 | PF12171 | |
| Domain | TUDOR | 4.32e-03 | 23 | 80 | 2 | PS50304 | |
| Domain | Bromodomain_CS | 5.51e-03 | 26 | 80 | 2 | IPR018359 | |
| Domain | AMP-binding_CS | 5.51e-03 | 26 | 80 | 2 | IPR020845 | |
| Domain | TUDOR | 5.93e-03 | 27 | 80 | 2 | SM00333 | |
| Domain | AMP_BINDING | 6.37e-03 | 28 | 80 | 2 | PS00455 | |
| Domain | AMP-binding | 7.29e-03 | 30 | 80 | 2 | PF00501 | |
| Domain | Tudor | 7.29e-03 | 30 | 80 | 2 | IPR002999 | |
| Domain | AMP-dep_Synth/Lig | 7.29e-03 | 30 | 80 | 2 | IPR000873 | |
| Domain | Sema | 7.77e-03 | 31 | 80 | 2 | SM00630 | |
| Domain | Semap_dom | 7.77e-03 | 31 | 80 | 2 | IPR001627 | |
| Domain | Sema | 7.77e-03 | 31 | 80 | 2 | PF01403 | |
| Domain | SEMA | 7.77e-03 | 31 | 80 | 2 | PS51004 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CEP350 FOXO3 FSIP2 ABL2 MAST4 PPFIBP1 RAB3GAP2 CCSER2 NUMB TNKS1BP1 WNK1 PABIR2 | 7.26e-07 | 861 | 81 | 12 | 36931259 |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 38804708 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10070062 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22842574 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27571988 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34403156 | ||
| Pubmed | CRL4 complex regulates mammalian oocyte survival and reprogramming by activation of TET proteins. | 7.33e-06 | 53 | 81 | 4 | 24357321 | |
| Pubmed | 9.82e-06 | 57 | 81 | 4 | 36849460 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 TDRD3 EXOSC10 SEC23IP ZNF638 NUMB AASDHPPT TNKS1BP1 PFKM WNK1 ZNF281 | 1.08e-05 | 934 | 81 | 11 | 33916271 |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 16822332 | ||
| Pubmed | Genetic Variations in AMPK, FOXO3A, and POMC Increase the Risk of Extreme Obesity. | 1.60e-05 | 3 | 81 | 2 | 39484290 | |
| Pubmed | The amino-terminal domain of glutamate receptor delta2 triggers presynaptic differentiation. | 1.60e-05 | 3 | 81 | 2 | 19000899 | |
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 1.60e-05 | 3 | 81 | 2 | 11592977 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 1.60e-05 | 3 | 81 | 2 | 16407123 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TTBK2 RANBP2 RAB3GAP2 GSDMA TNKS1BP1 PZP SEC61A1 ITIH2 MOV10 | 2.00e-05 | 647 | 81 | 9 | 26618866 |
| Pubmed | 2.00e-05 | 493 | 81 | 8 | 15368895 | ||
| Pubmed | 2.24e-05 | 242 | 81 | 6 | 34011540 | ||
| Pubmed | GluRδ2 assembles four neurexins into trans-synaptic triad to trigger synapse formation. | 3.20e-05 | 4 | 81 | 2 | 22457515 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 29392534 | ||
| Pubmed | miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. | 3.20e-05 | 4 | 81 | 2 | 29361949 | |
| Pubmed | 3.30e-05 | 529 | 81 | 8 | 14621295 | ||
| Pubmed | Alternatively spliced isoforms of WT1 control podocyte-specific gene expression. | 3.82e-05 | 28 | 81 | 3 | 25993318 | |
| Pubmed | CNOT6 RANBP2 TDRD3 SEMA3C C18orf21 MAN2A1 ZNF592 PPFIBP1 NUMB YES1 ZNF281 TAF1L MOV10 | 4.05e-05 | 1497 | 81 | 13 | 31527615 | |
| Pubmed | 5.11e-05 | 730 | 81 | 9 | 34857952 | ||
| Pubmed | Functional heterogeneity of POMC neurons relies on mTORC1 signaling. | 5.33e-05 | 5 | 81 | 2 | 34644574 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 8817451 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CNOT6 DCAF1 FOXO3 PPFIBP1 SEC23IP ZNF638 NUMB TNKS1BP1 RPGR WNK1 PABIR2 MOV10 | 5.39e-05 | 1321 | 81 | 12 | 27173435 |
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 6.31e-05 | 33 | 81 | 3 | 26830346 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 34259627 | ||
| Pubmed | Expression of class 3 semaphorins and neuropilin receptors in the developing mouse tooth. | 7.99e-05 | 6 | 81 | 2 | 11231073 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 17942483 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 7748561 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 19959467 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 24241537 | ||
| Pubmed | 8.69e-05 | 99 | 81 | 4 | 34161765 | ||
| Pubmed | 1.14e-04 | 469 | 81 | 7 | 27634302 | ||
| Pubmed | 1.32e-04 | 209 | 81 | 5 | 36779422 | ||
| Pubmed | Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. | 1.49e-04 | 8 | 81 | 2 | 2034279 | |
| Pubmed | Physical mapping of 2000 kb of the mouse X chromosome in the vicinity of the Xist locus. | 1.49e-04 | 8 | 81 | 2 | 8468051 | |
| Pubmed | Semaphorins III and IV repel hippocampal axons via two distinct receptors. | 1.49e-04 | 8 | 81 | 2 | 9753685 | |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 20006658 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 11906695 | ||
| Pubmed | Genetic mapping in the region of the mouse X-inactivation center. | 1.49e-04 | 8 | 81 | 2 | 1974879 | |
| Pubmed | Deletion of Prl7d1 causes placental defects at mid-pregnancy in mice. | 1.49e-04 | 8 | 81 | 2 | 31012985 | |
| Pubmed | High-density molecular map of the central span of the mouse X chromosome. | 1.49e-04 | 8 | 81 | 2 | 1675191 | |
| Pubmed | 1.63e-04 | 497 | 81 | 7 | 23414517 | ||
| Pubmed | 1.75e-04 | 503 | 81 | 7 | 16964243 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 12665565 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 8812066 | ||
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 1.91e-04 | 9 | 81 | 2 | 7874112 | |
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 34436835 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 9751712 | ||
| Pubmed | CNOT6 TDRD3 SEMA3C MAN2A1 PPFIBP1 NUMB TNKS1BP1 PFKM WNK1 YES1 SEC61A1 | 2.06e-04 | 1297 | 81 | 11 | 33545068 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 2.11e-04 | 364 | 81 | 6 | 24778252 | |
| Pubmed | GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. | 2.38e-04 | 10 | 81 | 2 | 25199915 | |
| Pubmed | HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments. | 2.38e-04 | 10 | 81 | 2 | 18215327 | |
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 2055107 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 18330979 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 18314154 | ||
| Pubmed | Characterization of a murine gene expressed from the inactive X chromosome. | 2.91e-04 | 11 | 81 | 2 | 2034278 | |
| Pubmed | Class 3 semaphorins negatively regulate dermal lymphatic network formation. | 2.91e-04 | 11 | 81 | 2 | 26319580 | |
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 19710420 | ||
| Pubmed | 3.08e-04 | 251 | 81 | 5 | 29778605 | ||
| Pubmed | 3.08e-04 | 251 | 81 | 5 | 29031500 | ||
| Pubmed | 3.44e-04 | 257 | 81 | 5 | 16335952 | ||
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 17452450 | ||
| Pubmed | RBM24 is a major regulator of muscle-specific alternative splicing. | 3.48e-04 | 12 | 81 | 2 | 25313962 | |
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 19812329 | ||
| Pubmed | Human Ccr4-Not complexes contain variable deadenylase subunits. | 3.48e-04 | 12 | 81 | 2 | 19558367 | |
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 23991118 | ||
| Pubmed | The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes. | 3.48e-04 | 12 | 81 | 2 | 24211586 | |
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 31320642 | ||
| Pubmed | The CEP19-RABL2 GTPase Complex Binds IFT-B to Initiate Intraflagellar Transport at the Ciliary Base. | 3.48e-04 | 12 | 81 | 2 | 28625565 | |
| Pubmed | 3.82e-04 | 263 | 81 | 5 | 34702444 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.86e-04 | 146 | 81 | 4 | 23892456 | |
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 3.99e-04 | 410 | 81 | 6 | 25814554 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 8012115 | ||
| Pubmed | Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons. | 4.11e-04 | 13 | 81 | 2 | 23534961 | |
| Pubmed | Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. | 4.11e-04 | 13 | 81 | 2 | 11557891 | |
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 4.11e-04 | 13 | 81 | 2 | 1740345 | |
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 4.11e-04 | 13 | 81 | 2 | 1772416 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 7805729 | ||
| Pubmed | 4.42e-04 | 418 | 81 | 6 | 34709266 | ||
| Pubmed | 4.79e-04 | 14 | 81 | 2 | 22955271 | ||
| Pubmed | Differential gene expression in migratory streams of cortical interneurons. | 4.79e-04 | 14 | 81 | 2 | 22103416 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.33e-04 | 283 | 81 | 5 | 30585729 | |
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 14580349 | ||
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 8892864 | ||
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 14697343 | ||
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 6.29e-04 | 16 | 81 | 2 | 18489001 | |
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 7.12e-04 | 17 | 81 | 2 | 17626059 | |
| Pubmed | 7.12e-04 | 17 | 81 | 2 | 2355006 | ||
| Pubmed | 7.57e-04 | 76 | 81 | 3 | 22323595 | ||
| Pubmed | 8.00e-04 | 18 | 81 | 2 | 26302206 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 8.42e-04 | 853 | 81 | 8 | 28718761 | |
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 15051154 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.18e-04 | 184 | 81 | 4 | 32908313 | |
| Pubmed | VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. | 9.91e-04 | 20 | 81 | 2 | 21658587 | |
| Pubmed | 9.91e-04 | 20 | 81 | 2 | 12560567 | ||
| Interaction | KIFAP3 interactions | 5.54e-06 | 112 | 80 | 6 | int:KIFAP3 | |
| Interaction | YWHAZ interactions | FOXO3 FSIP2 ABL2 MAST4 MS4A1 PTPRO PPFIBP1 CCSER2 ZNF638 NUMB GSDMA PFKM WNK1 SEC61A1 PLEKHG5 PABIR2 MOV10 | 1.32e-05 | 1319 | 80 | 17 | int:YWHAZ |
| Cytoband | 1q25.2 | 2.29e-05 | 31 | 81 | 3 | 1q25.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 2.26e-04 | 167 | 81 | 4 | chr1q25 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | FOXO3 RANBP2 SEMA3C MAN2A1 ZNF638 AASDHPPT RPGR PFKM WNK1 YES1 | 2.31e-06 | 481 | 81 | 10 | M3898 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CEP350 PIKFYVE FOXO3 RANBP2 TDRD3 SEMA3C MAN2A1 CCSER2 ZNF638 NUMB RPGR PLCE1 | 1.22e-05 | 856 | 81 | 12 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.38e-05 | 466 | 81 | 9 | M13522 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | FOXO3 TDRD5 BNC2 ABL2 MAST4 GRID2 ZNF385B RPGR SHCBP1L WNK1 ZP2 SEC61A1 CNR1 GGT5 | 8.13e-07 | 778 | 78 | 14 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | FOXO3 TDRD5 BNC2 NAALAD2 ABL2 MAST4 GRID2 RPGR SHCBP1L WNK1 ZP2 SEC61A1 | 2.29e-05 | 770 | 78 | 12 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.14e-05 | 117 | 78 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-05 | 74 | 81 | 4 | a50df7f4f7847b8aeff3fc6d521a69b50e05c719 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 160 | 81 | 5 | 86fde32f096eaf9ea3677f57169cdcc0a57bb8dd | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 176 | 81 | 5 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 176 | 81 | 5 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.79e-05 | 177 | 81 | 5 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | Severe_COVID-19-B_cell-B_cell|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.10e-05 | 183 | 81 | 5 | 5634e528001c389efd1e380f01ad40072f60e943 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-05 | 185 | 81 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 186 | 81 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 187 | 81 | 5 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.45e-05 | 189 | 81 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 81 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 81 | 5 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 190 | 81 | 5 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 81 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.58e-05 | 191 | 81 | 5 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.58e-05 | 191 | 81 | 5 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.65e-05 | 192 | 81 | 5 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-05 | 193 | 81 | 5 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.71e-05 | 193 | 81 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.71e-05 | 193 | 81 | 5 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.85e-05 | 195 | 81 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.85e-05 | 195 | 81 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.92e-05 | 196 | 81 | 5 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.92e-05 | 196 | 81 | 5 | 092caba6726d1acd409a8be335100764d0724e64 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.07e-05 | 198 | 81 | 5 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 3.07e-05 | 198 | 81 | 5 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.14e-05 | 199 | 81 | 5 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 3.14e-05 | 199 | 81 | 5 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 200 | 81 | 5 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 200 | 81 | 5 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.87e-05 | 110 | 81 | 4 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.05e-05 | 129 | 81 | 4 | a60935ff9c5a841899ccfe90531533ba4c546df3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.60e-05 | 131 | 81 | 4 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 134 | 81 | 4 | 8707210b2a5d33baa1d204e9e2ed8921181cb309 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 135 | 81 | 4 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-04 | 149 | 81 | 4 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 153 | 81 | 4 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-04 | 155 | 81 | 4 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 155 | 81 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 157 | 81 | 4 | d85a2f56ae313baa9738e81d2756ce1fe1ba50db | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.02e-04 | 159 | 81 | 4 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 160 | 81 | 4 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 160 | 81 | 4 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 2.07e-04 | 160 | 81 | 4 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 161 | 81 | 4 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp-Inhibitory_Gad1Gad2_Htr3a.Ibsp_(Interneuron,__(candidate_CGE-derived_7))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.16e-04 | 64 | 81 | 3 | c13a7edad4d52a955e2c2247139246522d9e4463 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp-Inhibitory_Gad1Gad2_Htr3a.Ibsp_(Interneuron,__(candidate_CGE-derived_7))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.16e-04 | 64 | 81 | 3 | eefb4573ec4ff8efe602543ccbe555dbef1c4d54 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.16e-04 | 64 | 81 | 3 | fcc0f3fa0b462620d031aae810a01fadb7c01202 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 163 | 81 | 4 | 73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 164 | 81 | 4 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 164 | 81 | 4 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 164 | 81 | 4 | 1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 164 | 81 | 4 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-04 | 164 | 81 | 4 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-04 | 164 | 81 | 4 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 164 | 81 | 4 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-04 | 164 | 81 | 4 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-04 | 164 | 81 | 4 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 164 | 81 | 4 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-04 | 165 | 81 | 4 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-04 | 165 | 81 | 4 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.49e-04 | 168 | 81 | 4 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.49e-04 | 168 | 81 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 169 | 81 | 4 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-04 | 169 | 81 | 4 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 169 | 81 | 4 | df1fc1477bbbb285063b9b122b1ac84c87fd7fa8 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 169 | 81 | 4 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 169 | 81 | 4 | 92986559aa4a744e8b0487b0ae035cfb1fbf9890 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-04 | 169 | 81 | 4 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.61e-04 | 170 | 81 | 4 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.67e-04 | 171 | 81 | 4 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.67e-04 | 171 | 81 | 4 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | PSB-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.73e-04 | 172 | 81 | 4 | 57b91bcce3f122f3d3267cf4d3a3ef67842caa9a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.73e-04 | 172 | 81 | 4 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.82e-04 | 70 | 81 | 3 | 05f8fc648641b9db50c2ae20d6246b52869957cf | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.98e-04 | 176 | 81 | 4 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.98e-04 | 176 | 81 | 4 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.98e-04 | 176 | 81 | 4 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.98e-04 | 176 | 81 | 4 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.04e-04 | 177 | 81 | 4 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-04 | 177 | 81 | 4 | 16197068260fc062bf8b730a51a199887ea580b9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-04 | 177 | 81 | 4 | ae55773c531099a9e94f44f01ba48b5e71dddc53 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.11e-04 | 178 | 81 | 4 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.17e-04 | 179 | 81 | 4 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.24e-04 | 180 | 81 | 4 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 180 | 81 | 4 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 180 | 81 | 4 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 3.38e-04 | 182 | 81 | 4 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.38e-04 | 182 | 81 | 4 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 3.38e-04 | 182 | 81 | 4 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 183 | 81 | 4 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | COVID-19_Severe-RBC|COVID-19_Severe / disease group, cell group and cell class | 3.52e-04 | 184 | 81 | 4 | bb58244194ffb5558fbe85c5f856888210dcb1e8 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-04 | 185 | 81 | 4 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| Disease | Calcium pyrophosphate deposition disease | 6.72e-06 | 2 | 77 | 2 | C0553730 | |
| Disease | alpha-1-antichymotrypsin complex measurement | 1.40e-04 | 7 | 77 | 2 | EFO_0008018 | |
| Disease | Headache, glucose measurement | 2.39e-04 | 9 | 77 | 2 | EFO_0004468, HP_0002315 | |
| Disease | beta-hydroxyisovalerate measurement | 5.99e-04 | 14 | 77 | 2 | EFO_0800125 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 6.14e-04 | 398 | 77 | 6 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Waxy flexibility | 6.90e-04 | 15 | 77 | 2 | C0233612 | |
| Disease | Catalepsy | 6.90e-04 | 15 | 77 | 2 | C0007370 | |
| Disease | Craniofacial Abnormalities | 7.54e-04 | 156 | 77 | 4 | C0376634 | |
| Disease | open-angle glaucoma | 1.59e-03 | 191 | 77 | 4 | EFO_0004190 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.10e-03 | 206 | 77 | 4 | C0152013 | |
| Disease | triglyceride measurement, response to escitalopram, response to citalopram | 2.26e-03 | 27 | 77 | 2 | EFO_0004530, EFO_0006329, EFO_0007871 | |
| Disease | Visual seizure | 2.37e-03 | 101 | 77 | 3 | C0270824 | |
| Disease | Epileptic drop attack | 2.37e-03 | 101 | 77 | 3 | C0270846 | |
| Disease | Generalized seizures | 2.37e-03 | 101 | 77 | 3 | C0234533 | |
| Disease | Clonic Seizures | 2.37e-03 | 101 | 77 | 3 | C0234535 | |
| Disease | Vertiginous seizure | 2.37e-03 | 101 | 77 | 3 | C0422855 | |
| Disease | Gustatory seizure | 2.37e-03 | 101 | 77 | 3 | C0422854 | |
| Disease | Seizures, Somatosensory | 2.37e-03 | 101 | 77 | 3 | C0422850 | |
| Disease | Olfactory seizure | 2.37e-03 | 101 | 77 | 3 | C0422853 | |
| Disease | Seizures, Auditory | 2.37e-03 | 101 | 77 | 3 | C0422852 | |
| Disease | Generalized Absence Seizures | 2.37e-03 | 101 | 77 | 3 | C4505436 | |
| Disease | Convulsive Seizures | 2.37e-03 | 101 | 77 | 3 | C0751494 | |
| Disease | Seizures, Sensory | 2.37e-03 | 101 | 77 | 3 | C0751496 | |
| Disease | Jacksonian Seizure | 2.37e-03 | 101 | 77 | 3 | C0022333 | |
| Disease | Non-epileptic convulsion | 2.37e-03 | 101 | 77 | 3 | C0751056 | |
| Disease | Atonic Absence Seizures | 2.37e-03 | 101 | 77 | 3 | C0751123 | |
| Disease | Complex partial seizures | 2.37e-03 | 101 | 77 | 3 | C0149958 | |
| Disease | Single Seizure | 2.37e-03 | 101 | 77 | 3 | C0751110 | |
| Disease | Epileptic Seizures | 2.37e-03 | 101 | 77 | 3 | C4317109 | |
| Disease | Nonepileptic Seizures | 2.37e-03 | 101 | 77 | 3 | C3495874 | |
| Disease | Tonic Seizures | 2.44e-03 | 102 | 77 | 3 | C0270844 | |
| Disease | Absence Seizures | 2.44e-03 | 102 | 77 | 3 | C4316903 | |
| Disease | Convulsions | 2.44e-03 | 102 | 77 | 3 | C4048158 | |
| Disease | cortical surface area measurement | CNOT6 FOXO3 BNC2 TCF4 SEMA3C MAST4 PPFIBP1 RAB3GAP2 MOV10 PLCE1 | 2.55e-03 | 1345 | 77 | 10 | EFO_0010736 |
| Disease | Seizures, Focal | 2.58e-03 | 104 | 77 | 3 | C0751495 | |
| Disease | Myoclonic Seizures | 2.58e-03 | 104 | 77 | 3 | C4317123 | |
| Disease | Tonic - clonic seizures | 2.58e-03 | 104 | 77 | 3 | C0494475 | |
| Disease | glutamate measurement | 2.61e-03 | 29 | 77 | 2 | EFO_0010487 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FRMKQGSYSTGFPVA | 221 | Q8NAT2 | |
| FGMTPKPTSQATGFA | 291 | Q68DN1 | |
| MKTSFPGRGSIPEFF | 131 | Q9NRN7 | |
| GFFSSFMKKRNAPTP | 651 | P42684 | |
| FGTRTTTAEPGFMGT | 81 | Q6ZN30 | |
| SDPTDTGNFGFKNML | 71 | Q96QA5 | |
| IYFTSGTTGFPKMAQ | 226 | P0C7M7 | |
| FGSKGFHPMVDSSTS | 106 | Q15782 | |
| SLVGPTQSFFMRESK | 36 | P11836 | |
| RRSDDMFTFHGPGKS | 1126 | P49792 | |
| VESGDMKGSFALSFP | 511 | P20742 | |
| SPFDQMKTASNIGGF | 276 | Q9H2M9 | |
| MKSPFGSSFRTFNAT | 1326 | Q9Y4B6 | |
| KGQSMFPVLSGDFFT | 481 | Q16706 | |
| ASFSQPGSMGLDKNT | 31 | Q8NI22 | |
| PKGAFISNFSMTVDG | 111 | P19823 | |
| MPANFTEGSFDSSGT | 1 | Q6W5P4 | |
| MDDNPFGTRKVRSSF | 511 | Q86W92 | |
| DFSAMFSPPVSSGKN | 21 | P15884 | |
| FSPGKMGPRATAEFS | 1491 | Q9UPA5 | |
| PRESNFGSFDQTMKG | 3246 | Q5CZC0 | |
| NGGFFRSPIKTMSSI | 971 | O43424 | |
| SASTFQLTGFPGMEK | 6 | Q9H340 | |
| GSPTPFDRNFATKMG | 666 | P08237 | |
| GKEAFSMTFGSPEFS | 421 | Q32MH5 | |
| RYGGFMTSEKSQTPL | 236 | P01189 | |
| CGPENFTTIFTRMGK | 171 | Q9UHC3 | |
| EKSTSGSFSFFPVQM | 331 | Q16827 | |
| TRGFGKMFVSSSGLP | 121 | Q7Z309 | |
| ASFTPAMGSIFQFGK | 456 | A6NF01 | |
| FSASEIGEGMFKAPS | 226 | A2PYH4 | |
| IGEGMFKAPSFSVAF | 231 | A2PYH4 | |
| MFSGRFPLKTDESGA | 41 | Q6PI47 | |
| SRSPFSGTMTVDGNK | 326 | Q9H7U1 | |
| PTKKASGMLSFFRGT | 1736 | Q9Y2I7 | |
| SGMLSFFRGTAGKSP | 1741 | Q9Y2I7 | |
| SVGNKSMSFPTGKSD | 861 | Q01780 | |
| SPPKSFRMSANGTLF | 176 | Q6ZTQ4 | |
| DTFPTNFRDSAGAMK | 156 | P05154 | |
| NMPFSGGQDSFSKFT | 1666 | Q5VT06 | |
| GFNFSTESMARPEGR | 301 | P36269 | |
| FFTGPMSDFKNVGLV | 61 | Q9HCJ1 | |
| TSFRGSPFQEKMTAG | 51 | P21554 | |
| LNTFSSKEPQRGMGF | 306 | Q6QEF8 | |
| PGRFSDNGFLMTEKT | 836 | O00462 | |
| GMKRSPSATGQSSFR | 2436 | O15021 | |
| SFPMFSKIAVTGTGA | 111 | Q96SL4 | |
| GFFSPKSRARTMSEQ | 261 | Q9ULM6 | |
| MSGSKGKSPASVFRT | 151 | Q32NC0 | |
| SFRGFPALSQKMSPF | 276 | P49757 | |
| ELMPDSGAVFTFGKS | 6 | Q92834 | |
| GLMQRSSSFPYTTKG | 406 | O43524 | |
| RDNSMQSRSGKGPSF | 406 | Q9H7E2 | |
| GAFTPNMRTTKEFPD | 381 | Q99985 | |
| VMGKDEREGNSPSFF | 781 | Q9HCE1 | |
| GRMSPGETASFNKTS | 1706 | Q9P212 | |
| GPMSKFARGSRFSVA | 1061 | Q8IZX4 | |
| EGPMSKFARGSRFSV | 1041 | P21675 | |
| NMKSKEPAVGSRFFS | 31 | Q7RTY7 | |
| MASGSKASVPADSFR | 1 | Q9BZQ2 | |
| FMSRNPDFKGGVSVA | 566 | Q9Y6Y8 | |
| FRISMTFKNNSPSGG | 936 | Q8IZF2 | |
| AIFFTSGTSGYPKMT | 231 | Q53FZ2 | |
| MASGFKKPSAASTGQ | 1 | Q12798 | |
| SGPSTSAFGREVDKM | 256 | O94827 | |
| MPLKSSVGSRRGFFT | 211 | Q96AN5 | |
| GFRPKDQTSVGMSFV | 246 | Q9BZJ4 | |
| FSPTTVNTGRGMEFE | 196 | P61619 | |
| RPGMCPSKTFGTFSS | 376 | Q13214 | |
| DSTFMNGDSARSFPG | 111 | Q92610 | |
| RVSGAGFSPSSKMEG | 1131 | Q9C0C2 | |
| DIKPSNFAMGRFPST | 141 | Q6IQ55 | |
| TGTRMETTFGPAFSA | 26 | Q6Q0C0 | |
| GSQFKSGSRVPMTFI | 836 | Q9Y2X9 | |
| KPFMSFPVDSSSAVG | 111 | Q569K4 | |
| ESGMPFTSSEVGKDF | 166 | Q9BWM5 | |
| ASFPENSMGKRGFSE | 41 | Q9C0G0 | |
| RASFAKSVIGTPEFM | 376 | Q9H4A3 | |
| SQFFGTTPSEKQGMA | 266 | Q9BR11 | |
| QKDFMSFSLPRVFSG | 156 | Q05996 | |
| NRSFFSVESGTKMSG | 281 | Q14966 | |
| PSGRSVVAGFSSGFM | 1796 | Q562E7 | |
| AVNFSSLSMTPFGGS | 51 | P07947 | |
| FGPSTRSAAMKLFTA | 431 | P23276 | |
| PGFTGSDSFRKVRMH | 321 | Q9Y3Q0 |